Frank Stokes Castle Biosciences Inc (CSTL) insider trading activity

Frank Stokes is Chief Financial Officer of CASTLE BIOSCIENCES INC. Currently has a direct ownership of 48,716 shares of CSTL, which is worth approximately $1.2 Million. The most recent transaction as insider was on Jun 17, 2021, when has been sold 1,273 shares (Common Stock) at a price of $2.39 per share, resulting in proceeds of $3,042. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 48.7K

12.44% 3M change

29.06% 12M change

Total Value Held $1.2 Million

Frank Stokes Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 17 2021	BUY Exercise of conversion of derivative security	$3,042 $2.39 p/Share	1,273 Added 15.04%	7,193 Common Stock
Jun 16 2021	SELL Open market or private sale	$155,420 $73.07 p/Share	2,127 Reduced 26.43%	5,920 Common Stock
Jun 16 2021	BUY Exercise of conversion of derivative security	$5,084 $2.39 p/Share	2,127 Added 20.91%	8,047 Common Stock
Jun 15 2021	SELL Open market or private sale	$847,032 $73.02 p/Share	11,600 Reduced 66.21%	5,920 Common Stock
Jun 15 2021	BUY Exercise of conversion of derivative security	$27,724 $2.39 p/Share	11,600 Added 39.84%	17,520 Common Stock
Jan 12 2021	SELL Open market or private sale	$585,750 $78.1 p/Share	7,500 Reduced 65.87%	3,886 Common Stock
Jan 12 2021	BUY Exercise of conversion of derivative security	$17,925 $2.39 p/Share	7,500 Added 39.71%	11,386 Common Stock
Jan 11 2021	SELL Open market or private sale	$586,950 $78.26 p/Share	7,500 Reduced 65.87%	3,886 Common Stock
Jan 11 2021	BUY Exercise of conversion of derivative security	$17,925 $2.39 p/Share	7,500 Added 39.71%	11,386 Common Stock
Dec 03 2020	BUY Exercise of conversion of derivative security	$6,760 $3.38 p/Share	2,000 Added 33.98%	3,886 Common Stock
Nov 13 2020	SELL Open market or private sale	$666,250 $51.25 p/Share	13,000 Reduced 87.33%	1,886 Common Stock
Nov 13 2020	BUY Exercise of conversion of derivative security	$31,070 $2.39 p/Share	13,000 Added 46.62%	14,886 Common Stock
Nov 12 2020	SELL Open market or private sale	$671,320 $51.64 p/Share	13,000 Reduced 87.33%	1,886 Common Stock
Nov 12 2020	BUY Exercise of conversion of derivative security	$31,070 $2.39 p/Share	13,000 Added 46.62%	14,886 Common Stock
Oct 14 2020	SELL Open market or private sale	$705,380 $54.26 p/Share	13,000 Reduced 87.33%	1,886 Common Stock
Oct 14 2020	BUY Exercise of conversion of derivative security	$31,070 $2.39 p/Share	13,000 Added 46.62%	14,886 Common Stock
Oct 13 2020	SELL Open market or private sale	$712,270 $54.79 p/Share	13,000 Reduced 87.33%	1,886 Common Stock
Oct 13 2020	BUY Exercise of conversion of derivative security	$31,070 $2.39 p/Share	13,000 Added 46.62%	14,886 Common Stock

Also insider at

XGN

EXAGEN INC. Healthcare

Director

Frank Stokes

Chief Financial Officer

Friendswood, TX

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CSTL shares.

Notify only if

Value

Insider Trading

Get notified when an Castle Biosciences Inc insider buys or sells CSTL shares.

Notify only if

Operation

Value

Type

News

Receive news related to CASTLE BIOSCIENCES INC

Track Activities on CSTL

Account